Evidence map›Paper›PMID 20370590›Full record

ReviewExpert review of molecular diagnostics2010

Evolving molecular diagnostics for familial cardiomyopathies: at the heart of it all.

Thomas E Callis, Brian C Jensen, Karen E Weck, Monte S Willis

Abstract readReview
In one paragraph

Review in Expert review of molecular diagnostics, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Role of non-coding variants in cardiovascular disease.Journal of cellular and molecular medicine · 2023
    Review
  3. Genetic predisposition study of heart failure and its association with cardiomyopathy.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2022
    Review
  4. Article
  5. Review
  6. Cardiomyopathies.Acta bio-medica : Atenei Parmensis · 2019
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Journal of cardiovascular development and disease · 2016
    Review
  14. Review
  15. Review
  16. Review
  17. Cardiovascular genomics.Journal of nursing scholarship : an official publication of Sigma Theta Tau International Honor Society of Nursing · 2013
    Review
  18. Article
  19. Mendelian Randomization Study on the Associations Between Genetically Predicted Cardiovascular Disease Subtypes and the Risk of Developing Cardiomyopathies.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Thomas E CallisPGxHealth Division, Clinical Data, Inc., 5 Science Park, New Haven, CT 06511, USA.
Brian C Jensen
Karen E Weck
Monte S Willis
University of North Carolina at Chapel Hill · US

Funding

Alpha-1-Adrenergic Receptor Subtypes in the Cells of the Human HeartK08HL096836 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI JENSEN, BRIAN C · 2009 to 2013
$663k
NHLBI NIH HHS 1K08HL096836-01NHLBI NIH HHS K08 HL096836
6 · The paper itself

Abstract

Cardiomyopathies are an important and heterogeneous group of common cardiac diseases. An increasing number of cardiomyopathies are now recognized to have familial forms, which result from single-gene mutations that render a Mendelian inheritance pattern, including hypertrophic cardiomyopathy, dilated cardiomyopathy, restrictive cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy and left ventricular noncompaction cardiomyopathy. Recently, clinical genetic tests for familial cardiomyopathies have become available for clinicians evaluating and treating patients with these diseases, making it necessary to understand the current progress and challenges in cardiomyopathy genetics and diagnostics. In this review, we summarize the genetic basis of selected cardiomyopathies, describe the clinical utility of genetic testing for cardiomyopathies and outline the current challenges and emerging developments.

Indexed as

CardiomyopathiesEchocardiographyGenetic Predisposition to DiseaseGenetic TestingGenotypeHumansMutationPathology, MolecularPhenotype

Identifiers

PMID20370590
PMCPMC5022563
OpenAlexW1987683355

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.